PRESTIGE-AF is the first of the larger trials in this scenario to report results. More data are needed to help guide ...

Seeing is believing. Patients shown proof of calcification adhered better to statins; those without CAC avoided overtreatment ...

Even with recommendations in place, hospitals were far from uniform in their anticoagulation approaches well into 2022.

Procedural planning and attention to detail can help, but heart teams should be realistic about what lies ahead, experts say.

A SCAI survey found high rates of spinal injury amid signs that careers could be longer with better prevention and management ...

Talking with C. Michael Gibson, David Austin reviews the phase III trial of enalapril for anthracycline-induced cardiotoxicity in lymphoma and breast cancer patients.

The approval is based on results of the AcT trial, where tenecteplase was comparable to alteplase for safety and efficacy.

A review highlights how, amid shifts in care delivery, US veterans can still find high quality at their VA medical center.

Intensifying oral diuretic therapy was linked to worse prognosis, but not everybody is sold on its use an endpoint.

Though arterial thrombotic risk was higher with hormonal contraception use, the absolute excess risks were low.

Guidance around complete revascularization and intracoronary imaging is strengthened, and Impella gets a recommendation.

Clinicians having unconscious pro-white bias led to low-value PAD care and greater risks for amputation in Black patients.